The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.
Related Posts
Can AI Companions Help Cure the Loneliness Epidemic?
Companion apps promise to make you less lonely. We decided to put them to the test.
Unilever to Double Down on India Under New Strategic Shift
CEO Hein Schumacher said India is the best opportunity for Unilever over the next couple of years and will be the key for all its […]
Equinor, Shell to Combine U.K. Assets
The energy majors will create a joint venture they say will be the biggest independent producer in the North Sea to help sustain domestic oil-and-gas […]